Perjeta (Perjeta/Herceptin) (pertuzumab)

pCPA File Number: 20814
Negotiation Status:
Negotiations were not pursued
Indication(s):
Neoadjuvant Breast Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: